These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11968453)

  • 1. The role of glycine and glycine receptors in myoclonus and startle syndromes.
    Schofield PR
    Adv Neurol; 2002; 89():263-74. PubMed ID: 11968453
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanisms of inherited startle syndromes.
    Rajendra S; Schofield PR
    Trends Neurosci; 1995 Feb; 18(2):80-2. PubMed ID: 7537418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion.
    Kingsmore SF; Giros B; Suh D; Bieniarz M; Caron MG; Seldin MF
    Nat Genet; 1994 Jun; 7(2):136-41. PubMed ID: 7920630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Startle and its disorders.
    Meinck HM
    Neurophysiol Clin; 2006; 36(5-6):357-64. PubMed ID: 17336782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation (V260M) in the middle of the M2 pore-lining domain of the glycine receptor causes hereditary hyperekplexia.
    del Giudice EM; Coppola G; Bellini G; Cirillo G; Scuccimarra G; Pascotto A
    Eur J Hum Genet; 2001 Nov; 9(11):873-6. PubMed ID: 11781706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonsense mutation in the alpha1 subunit of the inhibitory glycine receptor associated with bovine myoclonus.
    Pierce KD; Handford CA; Morris R; Vafa B; Dennis JA; Healy PJ; Schofield PR
    Mol Cell Neurosci; 2001 Feb; 17(2):354-63. PubMed ID: 11178872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.
    Shiang R; Ryan SG; Zhu YZ; Hahn AF; O'Connell P; Wasmuth JJ
    Nat Genet; 1993 Dec; 5(4):351-8. PubMed ID: 8298642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An additional family with Startle disease and a G1192A mutation at the alpha 1 subunit of the inhibitory glycine receptor gene.
    Schorderet DF; Pescia G; Bernasconi A; Regli F
    Hum Mol Genet; 1994 Jul; 3(7):1201. PubMed ID: 7981700
    [No Abstract]   [Full Text] [Related]  

  • 9. The novel hyperekplexia allele GLRA1(S267N) affects the ethanol site of the glycine receptor.
    Becker K; Breitinger HG; Humeny A; Meinck HM; Dietz B; Aksu F; Becker CM
    Eur J Hum Genet; 2008 Feb; 16(2):223-8. PubMed ID: 18043720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperekplexia caused by dominant-negative suppression of glyra1 function.
    Bellini G; Miceli F; Mangano S; Miraglia del Giudice E; Coppola G; Barbagallo A; Taglialatela M; Pascotto A
    Neurology; 2007 May; 68(22):1947-9. PubMed ID: 17536053
    [No Abstract]   [Full Text] [Related]  

  • 11. Two Japanese families with hyperekplexia who have a Arg271Gln mutation in the glycine receptor alpha 1 subunit gene.
    Kimura M; Taketani T; Horie A; Isumi H; Sejima H; Yamaguchi S
    Brain Dev; 2006 May; 28(4):228-31. PubMed ID: 16478653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Startle syndromes.
    Bakker MJ; van Dijk JG; van den Maagdenberg AM; Tijssen MA
    Lancet Neurol; 2006 Jun; 5(6):513-24. PubMed ID: 16713923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major and minor form of hereditary hyperekplexia.
    Tijssen MA; Vergouwe MN; van Dijk JG; Rees M; Frants RR; Brown P
    Mov Disord; 2002 Jul; 17(4):826-30. PubMed ID: 12210885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulation links conformation of a pore-flanking region to hyperekplexia-related dysfunction of the inhibitory glycine receptor.
    Breitinger HG; Lanig H; Vohwinkel C; Grewer C; Breitinger U; Clark T; Becker CM
    Chem Biol; 2004 Oct; 11(10):1339-50. PubMed ID: 15489161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiology of the startle syndrome and hyperekplexia.
    Brown P
    Adv Neurol; 2002; 89():153-9. PubMed ID: 11968441
    [No Abstract]   [Full Text] [Related]  

  • 16. The α1K276E startle disease mutation reveals multiple intermediate states in the gating of glycine receptors.
    Lape R; Plested AJ; Moroni M; Colquhoun D; Sivilotti LG
    J Neurosci; 2012 Jan; 32(4):1336-52. PubMed ID: 22279218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Startle disease].
    Okino S; Yamada M
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):403-5. PubMed ID: 12483911
    [No Abstract]   [Full Text] [Related]  

  • 18. Symptomatic hyperekplexia occurring as a result of pontine infarction.
    Kimber TE; Thompson PD
    Mov Disord; 1997 Sep; 12(5):814-6. PubMed ID: 9380074
    [No Abstract]   [Full Text] [Related]  

  • 19. The startle syndromes: physiology and treatment.
    Dreissen YE; Tijssen MA
    Epilepsia; 2012 Dec; 53 Suppl 7():3-11. PubMed ID: 23153204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine receptors: a startling connection.
    Floeter MK; Hallett M
    Nat Genet; 1993 Dec; 5(4):319-20. PubMed ID: 8298635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.